Related Experiment Videos
Severe pulmonary vascular occlusive disease following bone marrow transplantation in Omenn syndrome
C Brückmann1, W Lindner, R Roos
1Universitäts-Kinderklinik München, Federal Republic of Germany.
Insights
Omenn syndrome, a severe immunodeficiency, was treated with bone marrow transplantation. While successful, complications arose, but the infant recovered with supportive care, highlighting a novel treatment approach for this rare condition.
Area of Science:
- Immunology
- Pediatric Hematology/Oncology
- Transplantation Medicine
Background:
- Omenn syndrome is a rare, severe combined immunodeficiency characterized by reticuloendotheliosis and hypereosinophilia, leading to recurrent infections and organ damage.
- Infants with Omenn syndrome often present with significant clinical challenges, including endomyocardial disease, necessitating aggressive treatment strategies.
Observation:
- A 5-month-old infant diagnosed with Omenn syndrome experienced recurrent infections and endomyocardial disease.
- The patient underwent bone marrow transplantation from an HLA-identical donor following chemotherapeutic conditioning, achieving initial immunological and clinical recovery.
Findings:
- Post-transplantation, the patient developed severe pulmonary occlusive disease, a serious complication.
- Gradual recovery was achieved with supportive measures, including increased inspiratory oxygen and the administration of nifedipine, a calcium channel blocker.
Implications:
- This case highlights the potential efficacy of bone marrow transplantation in treating Omenn syndrome.
- The successful management of post-transplantation pulmonary occlusive disease underscores the importance of tailored supportive care in pediatric transplantation.
- Further research into managing Omenn syndrome and its complications is warranted to improve patient outcomes.
Abstract:
A 5-month-old infant presented with severe combined immunodeficiency disease, reticuloendotheliosis, and hypereosinophilia (Omenn syndrome) resulting in recurrent infections and endomyocardial disease. Bone marrow transplantation from an HLA-identical donor after chemotherapeutic conditioning led to both immunological and clinical recovery. Bone marrow transplantation, however, was followed by severe pulmonary occlusive disease. The patient gradually recovered while on increased inspiratory oxygen and the calcium channel blocker nifedipine.